Can a single Gene-Editing injection stop a blinding corneal disease?
⭐️ CURE ⭐️
Not yet recruiting
This trial tests a single injection of GEB-101, a gene-editing treatment, directly into the cornea of people with TGFBI-related corneal dystrophy, a hereditary condition that causes progressive vision loss. The study aims to see if the treatment is safe and whether it can slow or…
Phase: PHASE1, PHASE2 • Sponsor: GenEditBio Limited • Aim: ⭐️ CURE ⭐️
Last updated Aug 08, 2026 00:03 UTC